| Literature DB >> 24688454 |
Aurora Reiss1, Mariana Carmen Chifiriuc2, Emilia Amzoiu3, Cezar Ionuţ Spînu1.
Abstract
New [ML2(H2O)2] complexes, where M =Entities:
Year: 2014 PMID: 24688454 PMCID: PMC3944908 DOI: 10.1155/2014/926287
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
1H and 13C NMR spectral data of the ligand and Zn(II) complex.
| Compound |
1H NMR |
13C NMR |
|---|---|---|
| Schiff base (L) | 2.10 (3H, s, COOCH3); 4.72, 4.90 (2H, AB, | 163.0; 143.4; 109.9 (C17; C15; C16–thiazole ring); 168.39 (C13); 169.3; (C12); 58.12; 65.4; 171.4 (C5; C7; C6
|
|
| ||
| ZnL2(H2O)2
| 2.10 (3H, s, COOCH3); 4.72, 4.90 (2H, AB, | 163.0; 143.4; 109.9 (C17; C15; C16 thiazole ring); 168.39 (C13); 169.3; (C12); 58.12; 65.4; 171.4 (C5; C7; C6
|
Figure 1Chemical structure of the Schiff base.
Relevant IR data (cm−1) of the ligand and its complexes.
| Compound |
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| Cefotaxime-Na | — | 3442 | — | 1776 | — | 1640 | — | — | — |
| Schiff base (L) | — | — | 2800 | 1770 | 1657 | 1645 | 1274 | — | — |
| [CoL2(H2O)2] | 3530 | — | — | 1770 | 1624 | 1640 | 1295 | 863 | 419 |
| [NiL2(H2O)2] | 3545 | — | — | 1770 | 1623 | 1640 | 1305 | 863 | 420 |
| [CuL2(H2O)2] | 3540 | — | — | 1770 | 1620 | 1645 | 1295 | 860 | 427 |
| [ZnL2(H2O)2] | 3543 | — | — | 1770 | 1630 | 1640 | 1310 | 857 | 423 |
Figure 2IR spectra of the Schiff base (a) and its complexes: [CoL2(H2O)2] (b); [NiL2(H2O)2] (c); [CuL2(H2O)2] (d).
Figure 3UV-Vis spectra of the Schiff base (a) and its complexes: [CoL2(H2O)2] (b); [NiL2(H2O)2] (c); [CuL2(H2O)2] (d).
Absorption maxima from electronic spectra, magnetic moments, and crystal field parameters for Schiff base (L) and its complexes.
| Compound | Absorption maxima (cm−1) | Assignments |
| Crystal field parameters | ||
|---|---|---|---|---|---|---|
| 10Dq (cm1) |
|
| ||||
| L | 38460 |
| — | — | — | — |
| [CoL2(H2O)2] | 22936 |
| 4.78 | 1071 | 724 | 0.748 |
| [CuL2(H2O)2] | 23094 |
| 1.86 | 1429 | — | — |
| [NiL2(H2O)2] | 27070 |
| 3.12 | 1012 | 793 | 0.752 |
| [ZnL2(H2O)2] | 19800 | C.T. (L → M) | — | — | — | |
Figure 4Thermogravimetric curves for Ni(II) complex (a) and Cu(II) complex (b).
Thermogravimetric data of Co(II), Ni(II), and Cu(II) complexes.
| Complex | Steps | Thermal effect | Temperature range (°C) | Δ | Δ | Lost fragment |
|---|---|---|---|---|---|---|
| [CoL2(H2O)2] | 1 | Endothermic | 70–117 | 11.53 | 11.63 | C6O4H10 |
| 2 | Exothermic | 117–197 | 2.55 | 2.86 | 2 | |
| 3 | Exothermic | 197–294 | 32.71 | 32.67 | C14H8O6S2N2Na2 | |
| 4 | Endothermic | 294–453 | 15.61 | 15.93 | C6O4H8N4 | |
| 5 | Exothermic | 453–595 | 32.75 | 32.19 | degradation products + | |
| 4.58 | 4.69 | metallic oxide residue | ||||
|
| ||||||
| [NiL2(H2O)2] | 1 | Endothermic | 75–125 | 11.73 | 11.63 | C6O4H10 |
| 2 | Exothermic | 125–205 | 2.35 | 2.86 | 2 | |
| 3 | Exothermic | 205–302 | 31.71 | 32.67 | C14H8O6S2N2Na2 | |
| 4 | Endothermic | 302–460 | 14.61 | 15.93 | C6O4H8N4 | |
| 5 | Exothermic | 460–602 | 31.75 | 32.19 | degradation products + | |
| 4.78 | 4.72 | metallic oxide residue | ||||
|
| ||||||
| [CuL2(H2O)2] | 1 | Endothermic | 80–127 | 11.79 | 11.59 | C6O4H10 |
| 2 | Exothermic | 127–207 | 2.55 | 2.85 | 2 | |
| 3 | Exothermic | 207–304 | 32.71 | 32.55 | C14H8O6S2N2Na2 | |
| 4 | Endothermic | 304–463 | 15.61 | 15.87 | C6O4H8N4 | |
| 5 | Exothermic | 463–605 | 32.15 | 32.07 | Degradation products + | |
| 4.98 | 5.04 | metallic oxide residue | ||||
Scheme 1Fragmentation of Co(II), Ni(II), and Cu(II) complexes following the thermal decomposition.
Structural descriptors of the studied compounds.
| Compound | Interatomic distances, Å | ||||||
|---|---|---|---|---|---|---|---|
| C37–C38 | C38–C39 | N1–C46 | N1–C2 | C2–C3 | C3–C4 | C7–N13 | |
| L | 1.4394 | 1.5182 | 1.4435 | 1.3865 | 1.5110 | 1.3466 | 1.3412 |
| [NiL2(H2O)2] | 1.4093 | 1.5297 | 1.4520 | 1.3728 | 1.3602 | 1.3596 | 1.2647 |
| [CuL2(H2O)2] | 1.4091 | 1.5298 | 1.4519 | 1.3727 | 1.3601 | 1.3569 | 1.2642 |
| [ZnL2(H2O)2] | 1.4092 | 1.5299 | 1.4518 | 1.3726 | 1.3600 | 1.3568 | 1.2634 |
| [CoL2(H2O)2] | 1.4092 | 1.5300 | 1.4519 | 1.3726 | 1.3601 | 1.3570 | 1.2643 |
Figure 5Molecular structure of the complex [NiL2(H2O)2].
Structural descriptors of the studied compounds.
| Compound |
|
|
|
|
| OV |
|---|---|---|---|---|---|---|
| L | 80.277 | 559.57 | 6.415 | 53.32 | 1361.67 | 1.6856 |
| [NiL2(H2O)2] | 277.223 | 1211.86 | 11.26 | 107.54 | 2603.47 | 1.9871 |
| [CuL2(H2O)2] | 287.481 | 1216.70 | 11.55 | 107.58 | 2605.22 | 1.9814 |
| [ZnL2(H2O)2] | 284.497 | 1218.52 | 11.69 | 107.59 | 2613.30 | 1.9800 |
| [CoL2(H2O)2] | 285.611 | 1212.08 | 11.56 | 107.56 | 2604.48 | 1.9815 |
Qualitative screening of the susceptibility spectra of various microbial strains to the synthesized compounds (mm).
| Number | Compound |
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | L | — | 6 | — | — | — | — | — | — | 7 |
| 2 | [NiL2(H2O)2] | — | 6 | 7 | — | — | — | — | 8 | 11 |
| 3 | [CuL2(H2O)2] | 16 | 14 | 17 | 7 | — | — | 14 | 15 | 15 |
| 4 | [ZnL2(H2O)2] | 7 | 7 | 7 | 9 | 7 | 6 | 10 | 11 | 9 |
| 5 | [CoL2(H2O)2] | 11 | 16 | 8 | 6 | 6 | 8 | 7 | 8 | 12 |
| DMSO-control | — | — | — | — | 3 | — | — | 6 | 5 | |
| Antibiotic control | Cefotaxime | — | 7 | 6 | 7 | 6 | 6 | 6 | — | — |
Minimum inhibitory concentration (MIC) (µg/mL) of the synthesized compounds.
| Number | Compound |
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | L | — | 0.5 | — | — | — | — | — | — | |
| 2 | [NiL2(H2O)2] | — | 0.5 | 1 | — | — | — | — | — | 1 |
| 3 | [CuL2(H2O)2] | 0.0625 | 0.033 | 0.125 | 0.5 | — | — | 1 | 1 | 0.5 |
| 4 | [ZnL2(H2O)2] | 0.5 | 0.25 | 0.5 | 0.5 | 1 | — | 1 | 1 | 1 |
| 5 | [CoL2(H2O)2] | 1 | 0.25 | 1 | 0.5 | — | 1 | 1 | 1 | 1 |
| DMSO-control | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Figure 6Proposed structures of the metal(II) complexes.
Figure 7The intensity of S. aureus 1263 biofilm (quantified by A 490 nm on y-axis) developed in the presence of three successive binary concentrations, that is, 1 mg/mL, 500 μg/mL, and 250 μg/mL of the tested compounds (NC: negative, sterility control; PC: positive, growth control).
Figure 9The intensity of E. coli 13529 biofilm (quantified by A 490 nm on y-axis) developed in the presence of three successive binary concentrations, that is, 1 mg/mL, 500 μg/mL, and 250 μg/mL of the tested compounds (NC: negative, sterility control; PC: positive, growth control).
Figure 8The intensity of S. aureus 13204 biofilm (quantified by A 490 nm on y-axis) developed in the presence of three successive binary concentrations, that is, 1 mg/mL, 500 μg/mL and 250 μg/mL of the tested compounds (NC: negative, sterility control; PC: positive, growth control).
Figure 10The intensity of E. coli 12147 biofilm (quantified by A 490 nm on y-axis) developed in the presence of three successive binary concentrations, that is, 1 mg/mL, 500 μg/mL, and 250 μg/mL of the tested compounds (NC: negative, sterility control; PC: positive, growth control).
Figure 11The intensity of K. pneumoniae 13420 biofilm (quantified by A 490 nm on y-axis) developed in the presence of three successive binary concentrations, that is, 1 mg/mL, 500 μg/mL, and 250 μg/mL of the tested compounds (NC: negative, sterility control; PC: positive, growth control).
Figure 12The intensity of K. pneumoniae 1204 biofilm (quantified by A 490 nm on y-axis) developed in the presence of three successive binary concentrations, that is, 1 mg/mL, 500 μg/mL, and 250 μg/mL of the tested compounds (NC: negative, sterility control; PC: positive, growth control).